PCRX Pacira BioSciences, Inc. - Common Stock
NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 4, 2026
$25.21
· % 处于52周区间
· 高于低点
· 至高点
$18.8052周低点
$27.6652周高点
市值 (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
收入 (TTM)
$746M
PCRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$25.21
市值 (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
收入 (TTM)
$746M
ROE (TTM)
2.0%
负债/权益 (MRQ)
0.5
52周区间
$19–$28
PCRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$726M2016-12-31 → 2025-12-31
EPS$0.162016-12-31 → 2025-12-31
自由现金流$137M2016-12-31 → 2025-12-31
净利率2.0%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | PCRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 70.05年均值 ≈74.0 | ≈74.0 | · | · | |
| P/S (TTM) | 1.35年均值 ≈2.5 | ≈2.5 | · | · | |
| 市净率 (MRQ) | 1.55年均值 ≈2.1 | ≈2.1 | 3.7 | 低估 | |
| 企业价值 / EBITDA (TTM) | 10.6 | · | · | · | |
| 股价/自由现金流 (TTM) | 5.65年均值 ≈14.6 | ≈14.6 | · | · | |
| 市现率 (TTM) | 5.35年均值 ≈11.1 | ≈11.1 | · | · | |
| 市值/营收 (TTM) | 1.5 | · | · | · | |
| 市值/自由现金流 (TTM) | 6.2 | · | · | · | |
| 市净率（有形资产） (MRQ) | 2.65年均值 ≈9.5 | ≈9.5 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | PCRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 2.7%5年均值 ≈10.3% | ≈10.3% | -2342.9% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | 14.1%5年均值 ≈21.0% | ≈21.0% | -1487.9% | 顶尖 | |
| 税前利润率 (TTM) | 2.4%5年均值 ≈6.0% | ≈6.0% | -414.1% | 顶尖 | |
| 净利润率 (TTM) | 2.0%5年均值 ≈4.3% | ≈4.3% | -1320.1% | 顶尖 | |
| ROA (TTM) | 1.1%5年均值 ≈0.01% | ≈0.01% | -34.1% | 顶尖 | |
| ROE (TTM) | 2.0%5年均值 ≈0.14% | ≈0.14% | -39.7% | 顶尖 | |
| ROIC | 0.75%5年均值 ≈2.2% | ≈2.2% | -30.5% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | PCRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.5 | · | 0.3 | 高负债 | |
| 流动比率 (MRQ) | 5.05年均值 ≈3.4 | ≈3.4 | 10.1 | 低流动性 | |
| 速动比率 (MRQ) | 3.15年均值 ≈2.6 | ≈2.6 | 9.0 | 低流动性 | |
| 长期负债/股东权益 (MRQ) | 0.5 | · | 0.3 | 高负债 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | PCRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 3.6%5年均值 ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 2.9%5年均值 ≈9.4% | ≈9.4% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 11.1% | · | · | · | |
| EPS YoY | 161.8%5年均值 ≈8.8% | ≈8.8% | · | · | |
| Net Income YoY (净利润同比增长) | 163.7%5年均值 ≈10.2% | ≈10.2% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | -22.2% | · | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | -45.5% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | -23.8% | · | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | -45.4% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | PCRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.4 | ≈0.4 | 0.2 | 顶尖 | |
| Inventory Turnover (库存周转率) | 1.15年均值 ≈1.6 | ≈1.6 | · | · | |
| Receivables Turnover (应收账款周转率) | 6.15年均值 ≈6.7 | ≈6.7 | 11.6 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$880.5K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-2.3%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 3, 2026 | $0.73 | $0.66 | 10.6% |
| 2026年3月31日 | 五月 6, 2026 | $0.60 | $0.57 | 4.4% |
| 2025年12月31日 | $0.57 | $0.92 | -38.2% | |
| 2025年9月30日 | $0.70 | $0.66 | 5.3% | |
| 2025年6月30日 | $0.74 | $0.72 | 2.1% | |
| 2025年3月31日 | $0.62 | $0.61 | 2.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Cost of Revenue | $150M | $170M | $185M | $199M | $140M | $117M | $107M | $87M | $88M | $110M | $72M | $77M | |
| R&D Expense | $117M | $82M | $76M | $85M | $56M | $59M | $72M | $56M | $57M | $46M | $29M | $19M | |
| SG&A Expense | $369M | $294M | $269M | $255M | $199M | $194M | $201M | $177M | $161M | $153M | $139M | $107M | |
| Operating Expenses | $707M | $774M | $587M | $607M | $452M | $383M | $411M | $321M | $312M | $308M | $240M | $203M | |
| Operating Income | $19M | $-73M | $88M | $60M | $90M | $46M | $10M | $16M | $-25M | $-32M | $9M | $-5M | |
| Interest Expense | · | · | $20M | $40M | $32M | $26M | $24M | $22M | $18M | $7M | $8M | $8M | |
| Interest Income | $23M | $20M | $11M | $5M | $896.0K | $5M | $7M | $6M | $4M | $1M | $678.0K | $382.0K | |
| Other Non-op | $-7M | $-373.0K | $-186.0K | $-11M | $-3M | $3M | $-5M | $-888.0K | $167.0K | $-82.0K | $-165.0K | $-159.0K | |
| Pretax Income | $17M | $-63M | $62M | $13M | $56M | $20M | $-11M | $-425.0K | $-42M | $-38M | $2M | $-14M | |
| Income Tax | $10M | $36M | $20M | $-3M | $14M | $-125M | $268.0K | $46.0K | $140.0K | $105.0K | $264.0K | $173.0K | |
| Net Income | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| EPS (Basic) | $0.16 | $-2.15 | $0.91 | $0.35 | $0.95 | $3.41 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.05 | $-0.39 | |
| EPS (Diluted) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 | |
| Shares (Basic) | 44,566,000 | 46,245,000 | 46,222,000 | 45,521,000 | 44,262,000 | 42,671,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 36,540,000 | 35,299,000 | |
| Shares (Diluted) | 45,042,000 | 46,245,000 | 51,979,000 | 46,538,000 | 45,630,000 | 43,682,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 41,301,000 | 35,299,000 | |
| EBITDA | $110M | $5M | $163M | $152M | $118M | $66M | $30M | $29M | $-11M | $-19M | $21M | $5M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $277M | $153M | $104M | $586M | $100M | $78M | $133M | $54M | $36M | $54M | $38M | |
| Short-term Investments | $80M | $208M | $125M | $185M | $71M | $422M | $214M | $251M | $257M | $137M | $102M | $119M | |
| Receivables | $124M | $113M | $106M | $98M | $96M | $53M | $48M | $38M | $32M | $30M | $26M | $22M | |
| Inventory | $153M | $125M | $104M | $96M | $99M | $65M | $58M | $49M | $41M | $31M | $62M | $29M | |
| Prepaid Expense | $33M | $22M | $22M | $15M | $15M | $12M | $11M | $8M | $7M | $9M | $6M | $4M | |
| Current Assets | $548M | $745M | $510M | $498M | $866M | $652M | $409M | $478M | $391M | $243M | $253M | $214M | |
| PP&E (Net) | $141M | $167M | $174M | $184M | $188M | $137M | $105M | $109M | $107M | $101M | $90M | $61M | |
| PP&E (Gross) | $278M | $300M | $309M | $301M | $274M | $215M | $180M | $170M | $156M | $139M | $115M | $81M | |
| Accum. Depreciation | $138M | $133M | $135M | $117M | $85M | $78M | $75M | $62M | $49M | $38M | $25M | $20M | |
| Goodwill | $20M | $0 | $163M | $163M | $145M | $100M | $100M | $62M | $55M | $47M | $31M | $24M | |
| Intangibles | $368M | $426M | $483M | $541M | $624M | $97M | $104M | $0 | · | $0 | $81.0K | $403.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | $657.0K | $825.0K | $624.0K | $406.0K | $3M | |
| Total Assets | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Accounts Payable | $15M | $19M | $16M | $15M | $11M | $10M | $13M | $14M | $15M | $8M | $9M | $7M | |
| Accrued Liabilities | $96M | $80M | $64M | $90M | $128M | $71M | $70M | $46M | $41M | $37M | $35M | $28M | |
| Current Liabilities | $121M | $310M | $97M | $148M | $521M | $253M | $108M | $61M | $56M | $45M | $150M | $140M | |
| Capital Leases | $36M | $45M | $55M | $65M | $72M | $71M | $41M | $0 | · | · | · | · | |
| Deferred Tax | $4M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $21M | $17M | $14M | $10M | $20M | $4M | $2M | $17M | $16M | $19M | $11M | $5M | |
| Total Liabilities | $572M | $775M | $704M | $906M | $1.34B | $655M | $476M | $368M | $349M | $172M | $169M | $155M | |
| Long-term Debt | $372M | $585M | $522M | $689M | · | · | · | · | · | $109M | $104M | $103M | |
| Total Debt | $372M | · | · | · | · | · | · | · | · | $119M | $119M | $120M | |
| Common Stock | $48.0K | $47.0K | $46.0K | $46.0K | $45.0K | $44.0K | $42.0K | $41.0K | $41.0K | $37.0K | $37.0K | $36.0K | |
| Paid-in Capital | $1.06B | $1.01B | $977M | $924M | $942M | $873M | $754M | $710M | $669M | $565M | $527M | $481M | |
| Retained Earnings | $-199M | $-206M | $-107M | $-149M | $-212M | $-254M | $-399M | $-388M | $-389M | $-346M | $-308M | $-310M | |
| Treasury Stock | $177M | $25M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $4M | $343.0K | $247.0K | $-380.0K | $167.0K | $318.0K | $322.0K | $-280.0K | $-454.0K | $-30.0K | $-52.0K | $-80.0K | |
| Stockholders' Equity | $693M | $778M | $870M | $775M | $730M | $620M | $355M | $321M | $279M | $219M | $218M | $171M | |
| Liabilities + Equity | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Shares Outstanding | 41,116,739 | 47,078,000 | 46,481,000 | 45,928,000 | 44,734,000 | 43,637,000 | 41,908,148 | 41,222,799 | 40,668,877 | 37,480,952 | 36,848,319 | 36,150,620 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $91M | $79M | $76M | $92M | $29M | $20M | $20M | $13M | $14M | $13M | $11M | $10M | |
| Stock-based Comp | $58M | $51M | $48M | $48M | $42M | $40M | $34M | $32M | $32M | $31M | $33M | $25M | |
| Deferred Tax | $6M | $21M | $16M | $-8M | $11M | $-127M | $-2M | $0 | $0 | · | · | · | |
| Amort. of Intangibles | $57M | $57M | $57M | $57M | $14M | $8M | $6M | $0 | $0 | $100.0K | $300.0K | $800.0K | |
| Restructuring | $4M | $9M | $1M | $0 | $0 | $-38.0K | $847.0K | $2M | · | · | · | · | |
| Other Non-cash | $-10M | $138M | $-26M | $-2M | $2M | $-2M | $30M | $4M | $15M | $27M | $-18M | $4M | |
| Operating Cash Flow | $152M | $189M | $155M | $145M | $126M | $77M | $71M | $49M | $18M | $33M | $28M | $27M | |
| CapEx | $15M | $11M | $15M | $30M | $46M | $38M | $10M | $15M | $19M | $25M | $40M | $23M | |
| Investing Cash Flow | $99M | $-83M | $78M | $-225M | $-21M | $-278M | $-128M | $21M | $-224M | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | · | |
| Stock Repurchased | $148M | $25M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-148M | $-25M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-370M | $17M | $-183M | $-402M | $381M | $222M | $4M | $9M | $224M | · | · | · | |
| Net Change in Cash | $-118M | $123M | $49M | $-481M | $486M | $22M | $-54M | $78M | · | · | · | · | |
| Taxes Paid | $9M | $11M | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $137M | $179M | $139M | $115M | $80M | $39M | $60M | $34M | $-1M | $9M | $-12M | $4M | |
| Levered FCF | · | · | $126M | $67M | $56M | $-147M | $36M | $10M | $-20M | $2M | $-19M | $-5M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.6% | · | 13.0% | 9.0% | 16.6% | 10.8% | 2.5% | 4.7% | -8.7% | -11.6% | 3.8% | -2.6% | |
| Net Margin | 0.97% | · | 6.2% | 2.4% | 7.8% | 33.9% | -2.6% | -0.14% | -14.9% | -13.7% | 0.75% | -6.9% | |
| Pretax Margin | 2.3% | · | 9.1% | 2.0% | 10.4% | 4.7% | -2.5% | -0.13% | -14.8% | -13.7% | 0.85% | -6.9% | |
| EBITDA Margin | 15.2% | · | 24.2% | 22.7% | 21.9% | 15.4% | 7.1% | 8.6% | -3.9% | -6.9% | 8.4% | 2.5% | |
| ROA | 0.50% | -6.4% | 2.6% | 0.85% | 2.5% | 13.8% | -1.5% | -0.07% | -8.4% | -9.7% | 0.52% | -5.5% | |
| ROE | 0.97% | -13.0% | 4.9% | 2.1% | 5.8% | 24.2% | -3.1% | -0.15% | -17.1% | -17.3% | 0.95% | -12.9% | |
| ROIC | 0.75% | -14.9% | 6.9% | 9.3% | 9.2% | 54.2% | 3.0% | 5.5% | -8.9% | -9.5% | 2.5% | -1.8% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 | 2.6 | 3.8 | 7.9 | 7.0 | 5.4 | 1.7 | 1.5 | |
| Quick Ratio | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 | 2.3 | 3.2 | 6.9 | 6.1 | 4.5 | 1.2 | 1.3 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | 0.5 | 0.5 | 0.7 | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 4.3 | 1.5 | 2.8 | 1.8 | 0.4 | 0.7 | -1.4 | -4.5 | 1.2 | -0.6 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | |
| Inventory Turnover | 1.1 | 1.5 | 1.8 | 2.0 | 1.7 | 1.9 | 2.0 | 1.9 | 2.4 | 2.4 | 1.6 | 3.5 | |
| Receivables Turnover | 6.1 | · | 6.6 | 6.8 | 7.3 | 8.5 | 9.8 | 9.7 | 9.3 | 9.9 | 10.3 | 10.7 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.86 | $16.83 | $18.72 | $16.87 | $16.33 | $14.20 | $8.47 | $7.79 | $6.87 | $5.84 | $5.93 | $4.73 | |
| Revenue / Share | $16.13 | · | $12.99 | $14.33 | $11.87 | $9.84 | $10.14 | · | $7.20 | $7.42 | $6.03 | · | |
| Cash Flow / Share | $3.37 | $4.10 | $2.98 | $3.12 | $2.76 | $1.76 | $1.70 | · | $0.45 | $0.90 | $0.70 | · | |
| Cash / Share | $3.86 | $5.99 | $3.30 | $2.27 | $13.09 | $2.29 | $1.87 | $3.21 | $1.33 | $0.96 | $1.55 | $1.04 | |
| EPS (TTM) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.6% | 3.9% | 1.2% | 23.1% | 26.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.9% | 9.0% | 16.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | 161.8% | -63.0% | -72.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -22.2% | · | -35.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -45.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | 163.7% | -62.1% | -71.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -23.8% | · | -33.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -45.4% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Net Income TTM | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| Market Cap | $1.06B | $871M | $1.57B | $1.77B | $2.69B | $2.61B | $1.90B | $1.77B | $1.86B | $1.21B | $2.83B | $3.21B | |
| Enterprise Value | $1.20B | · | · | · | · | · | · | · | · | $1.16B | $2.79B | $3.17B | |
| P/E | 161.8 | -8.8 | 37.9 | 113.6 | 65.4 | 18.0 | -167.8 | -4302.0 | -42.7 | -31.7 | 1919.8 | -227.3 | |
| P/S | 1.5 | 1.2 | 2.3 | 2.7 | 5.0 | 6.1 | 4.5 | 5.3 | 6.5 | 4.4 | 11.4 | 16.2 | |
| P/B | 1.5 | 1.1 | 1.8 | 2.3 | 3.7 | 4.2 | 5.3 | 5.5 | 6.6 | 5.5 | 13.0 | 18.7 | |
| P / Tangible Book | 3.5 | 2.5 | 7.0 | 24.9 | · | 6.2 | · | · | · | · | · | · | |
| P / Cash Flow | 7.0 | 4.6 | 10.1 | 12.2 | 21.4 | 33.9 | 26.9 | 36.3 | 104.4 | 36.2 | 97.6 | 125.8 | |
| P / FCF | 7.8 | 4.9 | 11.2 | 15.4 | 33.7 | 66.6 | 31.5 | 51.6 | -1253.6 | 138.5 | -230.5 | 895.3 | |
| EV / EBITDA | 10.9 | · | · | · | · | · | · | · | · | -60.5 | 133.3 | 650.6 | |
| EV / FCF | 8.8 | · | · | · | · | · | · | · | · | 132.3 | -227.2 | 885.0 | |
| EV / Revenue | 1.6 | · | · | · | · | · | · | · | · | 4.2 | 11.2 | 16.0 | |
| Earnings Yield | 0.62% | -11.4% | 2.6% | 0.88% | 1.5% | 5.6% | -0.60% | -0.02% | -2.3% | -3.2% | 0.05% | -0.44% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $177M | $197M | $180M | $181M | $169M | $187M | $169M | $178M | $167M | $181M | $164M | $169M | $160M | · | $167M | |
| Cost of Revenue | $44M | $36M | $40M | $34M | $41M | $34M | $40M | $39M | $44M | $47M | $48M | $40M | $48M | $49M | $62M | $51M | |
| R&D Expense | $30M | $28M | $38M | $26M | $28M | $25M | $24M | $19M | $20M | $18M | $19M | $21M | $19M | $17M | $18M | $19M | |
| SG&A Expense | $92M | $94M | $102M | $92M | $89M | $87M | $80M | $74M | $68M | $72M | $66M | $68M | $65M | $71M | $64M | $61M | |
| Operating Expenses | $188M | $170M | $195M | $173M | $173M | $167M | $163M | $308M | $150M | $154M | $148M | $146M | $130M | $163M | · | $146M | |
| Operating Income | $4M | $7M | $2M | $6M | $8M | $2M | $25M | $-140M | $28M | $13M | $33M | $18M | $40M | $-3M | $-10M | $21M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $4M | $10M | · | $10M | |
| Interest Income | $2M | $2M | $2M | $9M | $5M | $7M | $6M | $5M | $5M | $4M | $3M | $3M | $2M | $3M | $3M | $1M | |
| Other Non-op | $-34.0K | $-135.0K | $-172.0K | $-110.0K | $-11M | $4M | $-53.0K | $-122.0K | $-39.0K | $-159.0K | $515.0K | $-422.0K | $-269.0K | $-10.0K | $81.0K | $-11M | |
| Pretax Income | $3M | $5M | $571.0K | $10M | $-2M | $9M | $26M | $-139M | $37M | $14M | $34M | $17M | $38M | $-26M | $-18M | $2M | |
| Income Tax | $-2M | $2M | $-1M | $4M | $3M | $4M | $9M | $5M | $18M | $5M | $9M | $6M | $12M | $-7M | $-8M | $3M | |
| Net Income | $5M | $3M | $2M | $5M | $-5M | $5M | $16M | $-143M | $19M | $9M | $25M | $11M | $26M | $-20M | $-10M | $-693.0K | |
| EPS (Basic) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.36 | $-3.11 | $0.41 | $0.19 | $0.55 | $0.23 | $0.56 | $-0.43 | $-0.22 | $-0.02 | |
| EPS (Diluted) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.38 | $-3.11 | $0.39 | $0.19 | $0.58 | $0.23 | $0.51 | $-0.43 | $-0.19 | $-0.02 | |
| Shares (Basic) | 39,462,000 | 40,461,000 | · | 44,038,000 | 45,459,000 | 46,275,000 | · | 46,134,000 | 46,174,000 | 46,499,000 | · | 46,416,000 | 46,088,000 | 45,949,000 | · | 45,831,000 | |
| Shares (Diluted) | 40,300,000 | 40,910,000 | · | 44,459,000 | 45,459,000 | 46,526,000 | · | 46,134,000 | 50,539,000 | 52,193,000 | · | 52,067,000 | 52,054,000 | 45,949,000 | · | 45,831,000 | |
| EBITDA | $4M | $28M | · | $6M | $8M | $23M | · | $-140M | $28M | $32M | · | $18M | $40M | $17M | · | $21M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $206M | $144M | $159M | $148M | $300M | $284M | $277M | $246M | $247M | $184M | · | $99M | $87M | $36M | · | $109M | |
| Short-term Investments | $45M | $58M | $80M | $99M | $145M | $210M | $208M | $208M | $157M | $142M | · | $136M | $134M | $138M | · | $219M | |
| Receivables | $132M | $126M | $124M | $115M | $114M | $105M | $113M | $101M | $105M | $102M | · | $97M | $99M | $93M | · | $93M | |
| Inventory | $135M | $150M | $153M | $158M | $148M | $134M | $125M | $112M | $103M | $97M | · | $97M | $92M | $93M | · | $97M | |
| Prepaid Expense | $30M | $37M | $33M | $43M | $37M | $28M | $22M | $24M | $20M | $19M | · | $19M | $17M | $16M | · | $14M | |
| Current Assets | $615M | $515M | $548M | $563M | $746M | $760M | $745M | $690M | $632M | $543M | · | $447M | $429M | $376M | · | $533M | |
| PP&E (Net) | $130M | $136M | $141M | $147M | $155M | $164M | $167M | $167M | $169M | $172M | · | $176M | $180M | $182M | · | $194M | |
| PP&E (Gross) | $281M | $281M | $278M | $280M | $308M | $304M | $300M | $297M | $293M | $292M | · | $307M | $308M | $305M | · | $295M | |
| Accum. Depreciation | $151M | $145M | $138M | $133M | $153M | $140M | $133M | $130M | $124M | $120M | · | $131M | $128M | $123M | · | $102M | |
| Goodwill | $20M | $20M | $20M | $20M | $20M | $22M | $0 | $0 | $163M | $163M | $163M | $163M | $163M | $163M | · | $157M | |
| Intangibles | $285M | $353M | $368M | $382M | $423M | $435M | $426M | $440M | $455M | $469M | · | $498M | $512M | $526M | · | $581M | |
| Total Assets | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Accounts Payable | $18M | $14M | $15M | $18M | $30M | $23M | $19M | $19M | $19M | $9M | · | $17M | $24M | $17M | · | $13M | |
| Accrued Liabilities | $93M | $85M | $96M | $80M | $71M | $80M | $80M | $76M | $65M | $67M | · | $60M | $56M | $62M | · | $76M | |
| Current Liabilities | $122M | $109M | $121M | $107M | $313M | $315M | $310M | $306M | $93M | $93M | · | $94M | $109M | $99M | · | $132M | |
| Capital Leases | $39M | $34M | $36M | $39M | $41M | $44M | $45M | $48M | $50M | $52M | · | $57M | $60M | $62M | · | $65M | |
| Deferred Tax | $4M | $4M | $4M | $5M | $5M | $7M | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $27M | $25M | $21M | $25M | $25M | $24M | $17M | $13M | $13M | $13M | · | $12M | $12M | $12M | · | $19M | |
| Total Liabilities | $572M | $555M | $572M | $570M | $779M | $788M | $775M | $772M | $768M | $691M | · | $703M | $734M | $755M | · | $964M | |
| Long-term Debt | $363M | $368M | $372M | $377M | $580M | $583M | $585M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $363M | $368M | · | $377M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | $47.0K | $47.0K | $47.0K | $47.0K | $47.0K | · | $46.0K | $46.0K | $46.0K | · | $46.0K | |
| Paid-in Capital | $1.09B | $1.07B | $1.06B | $1.05B | $1.04B | $1.02B | $1.01B | $996M | $983M | $990M | · | $963M | $951M | $936M | · | $909M | |
| Retained Earnings | $-192M | $-196M | $-199M | $-201M | $-206M | $-202M | $-206M | $-222M | $-79M | $-98M | · | $-132M | $-143M | $-168M | · | $-139M | |
| Treasury Stock | $227M | $227M | $177M | $126M | $76M | $25M | $25M | $25M | $25M | · | · | · | · | · | · | · | |
| AOCI | $3M | $3M | $4M | $4M | $4M | $1M | $343.0K | $678.0K | $105.0K | $152.0K | · | $-10.0K | $-173.0K | $-137.0K | · | $-670.0K | |
| Stockholders' Equity | $672M | $654M | $693M | $727M | $758M | $799M | $778M | $750M | $879M | $892M | $870M | $832M | $808M | $768M | $775M | $770M | |
| Liabilities + Equity | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Shares Outstanding | 39,822,298 | 39,309,610 | 41,116,739 | 42,965,902 | 44,897,766 | 46,283,407 | 46,240,604 | 46,148,146 | 46,117,359 | 46,517,410 | 46,481,000 | 46,426,836 | 46,408,961 | 45,970,340 | 45,928,000 | 45,864,319 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21M | $21M | $21M | $21M | $27M | $21M | $21M | $20M | $19M | $18M | $18M | $18M | $19M | $20M | $30M | $20M | |
| Stock-based Comp | $15M | $14M | $13M | $14M | $15M | $15M | $12M | $13M | $13M | $13M | $12M | $13M | $11M | $12M | $13M | $13M | |
| Deferred Tax | · | · | $-4M | $8M | $752.0K | $1M | $4M | $1M | $13M | $3M | $7M | $5M | $11M | $-7M | $-11M | $702.0K | |
| Amort. of Intangibles | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Restructuring | · | · | $-54.0K | $4M | $0 | $0 | $808.0K | $1M | $996.0K | $6M | $0 | $173.0K | $936.0K | · | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-6M | · | · | · | $5M | · | · | · | $14M | · | · | |
| Operating Cash Flow | $57M | $26M | $44M | $61M | $12M | $35M | $33M | $54M | $53M | $49M | $48M | $44M | $43M | $19M | $42M | $43M | |
| CapEx | $1M | $3M | $218.0K | $4M | $3M | $9M | $2M | $4M | $2M | $3M | $2M | $3M | $3M | $7M | $5M | $5M | |
| Investing Cash Flow | $12M | $19M | $19M | $44M | $62M | $-26M | $-368.0K | $-52M | $-15M | $-16M | $8M | $-4M | $7M | $66M | $11M | $-48M | |
| Stock Repurchased | $0 | $50M | $48M | $50M | $50M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $-50M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-8M | $-59M | $-52M | $-257M | $-58M | $-3M | $-2M | $-3M | $25M | $-3M | $-2M | $-28M | $440.0K | $-154M | $-59M | $-8M | |
| Net Change in Cash | $62M | $-14M | $11M | $-153M | $17M | $7M | $31M | $-1M | $63M | $31M | $54M | $12M | $51M | $-69M | $-5M | $-13M | |
| Taxes Paid | $860.0K | $50.0K | $69.0K | $711.0K | $8M | $286.0K | $1M | $5M | $5M | $-245.0K | $2M | $1M | $594.0K | $201.0K | · | $112.0K | |
| Free Cash Flow | · | $23M | · | · | · | $27M | · | · | · | $46M | · | · | · | $13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $44M | · | · | · | $5M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.2% | 3.9% | · | 3.5% | 4.7% | 1.2% | · | -82.8% | 15.9% | 7.9% | · | 10.8% | 23.5% | -1.9% | · | 12.7% | |
| Net Margin | 2.4% | 1.6% | · | 3.0% | -2.7% | 2.9% | · | -85.1% | 10.6% | 5.4% | · | 6.6% | 15.2% | -12.2% | · | -0.41% | |
| Pretax Margin | 1.3% | 2.8% | · | 5.3% | -1.1% | 5.1% | · | -82.4% | 20.5% | 8.2% | · | 10.1% | 22.3% | -16.5% | · | 1.2% | |
| EBITDA Margin | 2.2% | 15.9% | · | 3.5% | 4.7% | 13.7% | · | -82.8% | 15.9% | 18.9% | · | 10.8% | 23.5% | 10.3% | · | 12.7% | |
| ROA | 0.33% | 0.21% | · | 0.39% | -0.30% | 0.30% | · | -9.4% | 1.2% | 0.58% | · | 0.66% | 1.6% | -1.1% | · | -0.04% | |
| ROE | 0.65% | 0.40% | · | 0.74% | -0.59% | 0.57% | · | -18.1% | 2.2% | 1.1% | · | 1.4% | 3.3% | -2.6% | · | -0.09% | |
| ROIC | 0.75% | 0.39% | · | 0.33% | 2.8% | 0.14% | · | -19.2% | 1.7% | 0.97% | · | 1.4% | 3.4% | -0.30% | · | -0.93% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.7 | · | 5.3 | 2.4 | 2.4 | · | 2.3 | 6.8 | 5.8 | · | 4.8 | 3.9 | 3.8 | · | 4.1 | |
| Quick Ratio | 3.1 | 3.0 | · | 3.4 | 1.8 | 1.9 | · | 1.8 | 5.5 | 4.6 | · | 3.5 | 2.9 | 2.7 | · | 3.2 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.0 | · | 5.1 | 10.3 | -0.3 | · | 2.2 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.7 | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.7 | 1.8 | 1.7 | · | 2.3 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.87 | $16.63 | · | $16.93 | $16.88 | $17.25 | · | $16.24 | $19.07 | $19.18 | · | $17.91 | $17.41 | $16.71 | · | $16.79 | |
| Revenue / Share | $4.77 | $4.34 | · | $4.04 | $3.98 | $3.63 | · | $3.65 | $3.52 | $3.20 | · | $3.15 | $3.26 | $3.49 | · | $3.65 | |
| Cash Flow / Share | · | $0.63 | · | · | · | $0.76 | · | · | · | $0.94 | · | · | · | $0.42 | · | · | |
| Cash / Share | $5.17 | $3.67 | · | $3.44 | $6.69 | $6.13 | · | $5.33 | $5.36 | $3.96 | · | $2.13 | $1.87 | $0.77 | · | $2.39 | |
| EPS (TTM) | $0.36 | $0.13 | · | $0.49 | $-2.74 | $-2.24 | · | $-1.95 | $1.39 | $1.51 | · | $0.12 | $-0.13 | $-0.24 | · | $0.41 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $746M | $735M | · | $717M | $706M | $703M | · | $695M | $690M | $682M | · | · | · | · | · | $654M | |
| Net Income TTM | $15M | $5M | · | $21M | $-127M | $-104M | · | $-91M | $64M | $70M | · | $7M | $-5M | $-10M | · | $21M | |
| Market Cap | $1.01B | $888M | · | $1.11B | $1.07B | $1.15B | · | $695M | $1.32B | $1.36B | · | $1.42B | $1.86B | $1.88B | · | $2.44B | |
| Enterprise Value | $1.12B | $1.05B | · | $1.24B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 70.5 | 173.8 | · | 52.6 | -8.7 | -11.1 | · | -7.7 | 20.6 | 19.4 | · | 255.7 | -308.2 | -170.0 | · | 129.7 | |
| P/S | 1.4 | 1.2 | · | 1.5 | 1.5 | 1.6 | · | 1.0 | 1.9 | 2.0 | · | · | · | · | · | 3.7 | |
| P/B | 1.5 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 0.9 | 1.5 | 1.5 | · | 1.7 | 2.3 | 2.4 | · | 3.2 | |
| P / Tangible Book | 2.8 | 3.2 | · | 3.4 | 3.4 | 3.4 | · | 2.2 | 5.0 | 5.2 | · | 8.3 | 14.0 | 23.9 | · | 76.8 | |
| P / Cash Flow | · | 34.6 | · | · | · | 32.4 | · | · | · | 27.7 | · | · | · | 98.1 | · | · | |
| EV / Revenue | 1.5 | 1.4 | · | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 1.4% | 0.58% | · | 1.9% | -11.5% | -9.0% | · | -13.0% | 4.9% | 5.2% | · | 0.39% | -0.32% | -0.59% | · | 0.77% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $726M | $701M | $675M | $667M | $542M |
| 营业利润率 % | 2.6% | · | 13.0% | 9.0% | 16.6% |
| 净收入 | $7M | $-100M | $42M | $16M | $42M |
| 稀释后每股收益 (EPS) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.5 | · | · | · | · |
| 流动比率 | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 |
| 速动比率 | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $137M | $179M | $139M | $115M | $80M |
机构持有人 (13F) 266 家申报者 · $1.2B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
266
持有价值
$1.2B
新仓位
36
已退出持仓
23
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 36 (0 与上一季度对比) | 23 (-16 与上一季度对比) | 79 (-8 与上一季度对比) | 85 (+5 与上一季度对比) | +308K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $170126377 | 6705809 | 14.10% | 股份 |
| VANGUARD GROUP INC | $124559276 | 4812955 | 10.32% | 股份 |
| Doma Perpetual Capital Management LLC | $70472634 | 2777794 | 5.84% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $61046258 | 2406238 | 5.06% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $53360107 | 2103245 | 4.42% | 股份 |
| STATE STREET CORP | $52261616 | 2059977 | 4.33% | 股份 |
| D. E. Shaw & Co., Inc. | $49479923 | 1950332 | 4.10% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $43986531 | 1733801 | 3.65% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $42915156 | 1691571 | 3.56% | 股份 |
| GOLDMAN SACHS GROUP INC | $38743263 | 1527129 | 3.21% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $29401072 | 1158693 | 2.44% | 股份 |
| MORGAN STANLEY | $29039913 | 1144654 | 2.41% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $25829019 | 1018093 | 2.14% | 股份 |
| UBS Group AG | $23345905 | 920217 | 1.94% | 股份 |
| Impax Asset Management Group plc | $19028185 | 750027 | 1.58% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $18383203 | 724604 | 1.52% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17525241 | 690786 | 1.45% | 股份 |
| GAGNON SECURITIES LLC | $15440613 | 608617 | 1.28% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $14294929 | 563458 | 1.18% | 股份 |
| NORTHERN TRUST CORP | $13364459 | 526782 | 1.11% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $10436533 | 411373 | 0.87% | 股份 |
| DEUTSCHE BANK AG\ | $9922232 | 391101 | 0.82% | 股份 |
| Jefferies Financial Group Inc. | $9389234 | 370092 | 0.78% | 股份 |
| Hillsdale Investment Management Inc. | $9201699 | 362700 | 0.76% | 股份 |
| Gagnon Advisors, LLC | $8946401 | 352637 | 0.74% | 股份 |
| JPMORGAN CHASE & CO | $8698627 | 346697 | 0.72% | 股份 |
| EASTERLY INVESTMENT PARTNERS LLC | $8550172 | 337019 | 0.71% | 股份 |
| Bridge City Capital, LLC | $7922975 | 312297 | 0.66% | 股份 |
| BARCLAYS PLC | $7869496 | 310189 | 0.65% | 股份 |
| Bank of New York Mellon Corp | $7531837 | 296880 | 0.62% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $7129402 | 281017 | 0.59% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $6633164 | 261457 | 0.55% | 股份 |
| Invesco Ltd. | $6326010 | 249350 | 0.52% | 股份 |
| BANK OF AMERICA CORP /DE/ | $6088952 | 240006 | 0.50% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $5966085 | 235163 | 0.49% | 股份 |
| Coppell Advisory Solutions LLC | $5592970 | 16 | 0.46% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $5562474 | 219254 | 0.46% | 股份 |
| FMR LLC | $5505316 | 217001 | 0.46% | 股份 |
| Empowered Funds, LLC | $5075852 | 200073 | 0.42% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $5068926 | 199800 | 0.42% | 股份 |
| ROYAL BANK OF CANADA | $4704000 | 185433 | 0.39% | 股份 |
| Banco Santander, S.A. | $4211420 | 166000 | 0.35% | 股份 |
| Robeco Institutional Asset Management B.V. | $4161036 | 164014 | 0.34% | 股份 |
| AMERIPRISE FINANCIAL INC | $4137744 | 163096 | 0.34% | 股份 |
| CITADEL ADVISORS LLC | $4114101 | 162164 | 0.34% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $4021427 | 158511 | 0.33% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3562811 | 140434 | 0.30% | 股份 |
| Public Sector Pension Investment Board | $3429720 | 135188 | 0.28% | 股份 |
| PDT Partners, LLC | $3358176 | 132368 | 0.28% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $3292062 | 129762 | 0.27% | 股份 |
激进投资者及 5%+ 股东 16 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation, DOMA2 LLC, Eric de Armas ×4 申报 | 2026年3月12日 | 7.30% | 修订 | 董事会活动 | SEC |
| Consonance Capital Management LP, Consonance Capman GP LLC, Mitchell Blutt ×5 申报 | 2019年9月6日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2014年3月18日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2013年7月26日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2013年4月2日 | · | 初始申报 | · | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2013年3月21日 | · | 初始申报 | · | SEC |
| Sanderling Venture Partners VI, L.P., Sanderling Ventures Management VI, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling VI Limited Partnership, Sanderling Venture Partners VI Co-Investment Fund, L.P., Middleton, McNeil, Mills & Associates VI, LLC, Fred A. Middleton ×4 申报 | 2013年3月21日 | · | 初始申报 | 被动投资 | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2012年9月28日 | · | 初始申报 | · | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2012年6月15日 | · | 初始申报 | · | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2012年3月19日 | · | 初始申报 | · | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2011年12月1日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2011年12月1日 | · | 初始申报 | 被动投资 | SEC |
| MPM BioVentures IV-QP, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, Todd Foley, James Paul Scopa, Vaughn M. Kailian, John Vander Vort | 2011年11月29日 | · | 初始申报 | 被动投资 | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2011年2月18日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2011年2月18日 | · | 初始申报 | · | SEC |
| MPM BioVentures IV Q-P, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, William Greene, James Paul Scopa, Ashley Dombkowski, Vaughn M. Kailian, John Vander Vort | 2011年2月18日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 44 位内幕人士 · 20 位高管 · 17 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Frank D. Lee | Chief Executive Officer | 2026年2月11日 A | 660831 | 0 | 0 | $0 |
| David M Stack | CEO and Chairman | 2023年6月14日 A | 186481 | 0 | 0 | $0 |
| Shawn Cross | Chief Financial Officer | 2026年4月23日 M | 105341 | 0 | 7 | $-1521351 |
| Max Reinhardt | President, Rest of World | 2023年6月7日 S | 29225 | 0 | 0 | $0 |
| James S Scibetta | President | 2017年6月5日 S | 25118 | 0 | 0 | $0 |
| Scott Braunstein | Chief Operating Officer | 2018年1月3日 A | 20982 | 0 | 0 | $0 |
| Jonathan Slonin | Chief Medical Officer | 2026年8月17日 S | 216384 | 0 | 3 | $-240431 |
| Lauren Riker | Senior Vice President, Finance | 2026年6月11日 S | 62284 | 0 | 3 | $-261266 |
| Kristen Williams | Chief Administrative Officer | 2026年6月4日 S | 167062 | 0 | 2 | $-498171 |
| Brendan Teehan | Chief Commercial Officer | 2026年2月11日 A | 100934 | 0 | 0 | $0 |
| Ronald J. Ellis Jr. | Chief Strategy Officer | 2023年6月7日 S | 30909 | 0 | 0 | $0 |
| Dennis Mcloughlin | Chief Customer Officer | 2023年6月7日 S | 38115 | 0 | 0 | $0 |
| Anthony Molloy | Chief Lgl & Compliance Officer | 2023年6月6日 S | 12877 | 0 | 0 | $0 |
| Charles Anthony Laranjeira | Chief Technical Officer | 2022年6月14日 M | 41752 | 0 | 0 | $0 |
| Richard Scranton | Chief Scientific Officer | 2019年11月8日 M | 16061 | 0 | 0 | $0 |
| Robert J. Weiland | Chief Commercial Officer | 2018年6月4日 S | 5088 | 0 | 0 | $0 |
| James B Jones | SVP & Chief Medical Officer | 2017年11月20日 S | 16823 | 0 | 0 | $0 |
| Taunia Markvicka | SVP, Chief Commercial Officer | 2015年3月17日 M | 8579 | 0 | 0 | $0 |
| Gary Patou | Chief Medical Officer | 2014年8月7日 M | 0 | 0 | 0 | $0 |
| John Pratt | General Manager, San Diego | 2013年6月13日 M | 0 | 0 | 0 | $0 |
| Marcelo Bigal | 董事 | 2026年6月10日 A | 17798 | 0 | 0 | $0 |
| Alethia Young | 董事 | 2026年6月10日 A | 17798 | 0 | 0 | $0 |
| Christopher Christie | 董事 | 2026年6月10日 A | 23059 | 0 | 0 | $0 |
| Samit Hirawat | 董事 | 2026年6月10日 A | 6405 | 0 | 0 | $0 |
| Mark Froimson | 董事 | 2026年6月10日 A | 26541 | 0 | 1 | $-10905 |
| Michael J. Yang | 董事 | 2026年6月10日 A | 19798 | 0 | 0 | $0 |
| Laura Brege | 董事 | 2026年6月10日 A | 30120 | 0 | 0 | $0 |
| Thomas G Wiggans | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Mark A. Kronenfeld | 董事 | 2025年6月11日 A | 31065 | 0 | 0 | $0 |
| Yvonne Greenstreet | 董事 | 2022年6月8日 A | 13247 | 0 | 0 | $0 |
| John P Longenecker PHD | 董事 | 2022年3月3日 M | 18823 | 0 | 0 | $0 |
| Andreas Wicki | 董事 | 2021年3月15日 S | 451324 | 0 | 0 | $0 |
| Dennis L Winger | 董事 | 2017年6月14日 A | 7490 | 0 | 0 | $0 |
| Fred A Middleton | 董事 | 2013年6月24日 S | 0 | 0 | 0 | $0 |
| Luke Evnin | 董事 | 2013年6月12日 A | 0 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% 所有者 | 2013年3月25日 S | 2233993 | 0 | 0 | $0 |
| Abraham Ceesay | · | 2025年9月4日 S | 9039 | 0 | 0 | $0 |
| Daryl Gaugler | · | 2024年12月31日 A | 115443 | 0 | 0 | $0 |
| Charles A. Reinhart III | · | 2024年6月12日 A | 51867 | 0 | 0 | $0 |
| Paul J Hastings | · | 2024年6月12日 A | 12724 | 0 | 0 | $0 |
| Gary W Pace | · | 2024年3月8日 S | 22127 | 0 | 0 | $0 |
| Roy Winston | · | 2023年8月2日 S | 52440 | 0 | 0 | $0 |
| Donald C. Manning | · | 2021年6月9日 A | 29520 | 0 | 0 | $0 |
| GORDON CARL L | · | 2011年2月8日 C | 2828941 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 58 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1.28% | 10029 NS | 2026年7月31日 | N-PORT |
| CAFG · Pacer Funds Trust | 0.74% | 8394 NS | 2026年7月31日 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trus... | 0.55% | 37961 SH | 2026年10月2日 | 每日 |
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.50% | 4607 SH | 2026年10月2日 | 每日 |
| RZG · Invesco Exchange-Traded Fund Trust | 0.50% | 23694 SH | 2026年10月2日 | 每日 |
| XSHQ · Invesco Exchange-Traded Fund Trus... | 0.24% | 27368 SH | 2026年10月2日 | 每日 |
| SCOW · Pacer Funds Trust | 0.23% | 151 NS | 2026年7月31日 | N-PORT |
| IHE · iShares Trust | 0.23% | 145471 SH | 2026年9月11日 | 每日 |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.18% | 39523 NS | 2026年7月31日 | N-PORT |
| CALF · Pacer Funds Trust | 0.15% | 202699 NS | 2026年7月31日 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.13% | 42794 SH | 2026年8月19日 | 每日 |
| FSMD · FIDELITY COVINGTON TRUST | 0.11% | 104986 NS | 2026年7月31日 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.11% | 30919 SH | 2026年8月19日 | 每日 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.11% | 46835 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.08% | 86154 SH | 2026年10月2日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.07% | 231891 NS | 2026年7月31日 | N-PORT |
| SMDX · Tidal Trust III | 0.07% | 3450 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.07% | 2809 SH | 2026年10月2日 | 每日 |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.06% | 5956 SH | 2026年10月2日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.06% | 31734 SH | 2026年8月19日 | 每日 |
| ROSC · Lattice Strategies Trust | 0.05% | 1241 NS | 2026年7月31日 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.05% | 137158 SH | 2026年8月19日 | 每日 |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.05% | 36708 SH | 2026年10月2日 | 每日 |
| VFQY · VANGUARD WELLINGTON FUND | 0.04% | 7883 SH | 2026年8月19日 | 每日 |
| DFAT · Dimensional ETF Trust | 0.04% | 204980 NS | 2026年7月31日 | N-PORT |
| RSSL · Global X Funds | 0.03% | 18945 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.03% | 1024328 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 228207 SH | 2026年8月19日 | 每日 |
| PKW · Invesco Exchange-Traded Fund Trust | 0.03% | 19806 SH | 2026年10月2日 | 每日 |
| EBIT · Harbor ETF Trust | 0.02% | 106 NS | 2026年7月31日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.02% | 542974 SH | 2026年8月19日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.02% | 2098 SH | 2026年10月2日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.02% | 90095 NS | 2026年7月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 17794 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 453622 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.01% | 854717 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 112735 SH | 2026年8月19日 | 每日 |
| TILT · FlexShares Trust | 0.01% | 7900 NS | 2026年7月31日 | N-PORT |
| WSML · iShares Trust | 0.01% | 2019 SH | 2026年9月11日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.01% | 118628 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 1277 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 6433 NS | 2026年7月31日 | N-PORT |
| IWO · iShares Trust | 0.01% | 28461 SH | 2026年9月11日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.00% | 9932 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 69932 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 12671 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 12150 SH | 2026年9月11日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.00% | 866 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1198792 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3506 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3388 SH | 2026年8月19日 | 每日 |
| IJR · iShares Trust | · | 2397496 SH | 2026年9月10日 | 每日 |
| IJT · iShares Trust | · | 374609 SH | 2026年9月9日 | 每日 |
| IWN · iShares Trust | · | 338098 SH | 2026年9月11日 | 每日 |
| XJR · iShares Trust | · | 5453 SH | 2026年8月31日 | 每日 |
| ISCB · iShares Trust | · | 1678 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 8216 SH | 2026年9月11日 | 每日 |
| SMMV · iShares Trust | · | 12184 SH | 2026年8月19日 | 每日 |
PCRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$30.00
+19.0%
3 23.1%
强烈买入
6 46.2%
买入
3 23.1%
持有
1 7.7%
卖出
0 0.0%
强烈卖出
12个月价格目标
9 位分析师 · 2026-10-01平均目标 $30.00 +19.0%
现在
当前价格 $25.21
最低$23.00
平均值$30.00
最高$38.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| YARW | · | · | · | · | · | · |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| SPTX | · | · | · | · | · | · |
| ANRO | $568M | -8.1 | · | · | -46.1% | · |
| ALMS | · | -3.4 | · | -1011.8% | -61.9% | · |
| APMD | · | · | · | · | · | · |
| SGP | · | · | · | · | 50.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 4, 2026 申报